APREPITANT 40 MG CAP 1 UD Flavia and bergamot create a distinctive
APREPITANT 40 MG CAP 1 UD Flavia and bergamot create a distinctiveAprepitant 40 mg capsules provide targeted prevention of chemotherapy induced nausea and vomiting by blocking neurokinin 1 (NK1) receptors involved in vomiting reflex pathways. This formulation is designed for convenient single dose administration, facilitating adherence to antiemetic treatment protocols. When used as part of a combination regimen with other antiemetics, Aprepitant improves patient comfort and quality of life during cancer therapy by
Pay in 4 interest-free payments of $42.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3